MDCL - Medicine Man Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.9000
+0.2600 (+15.85%)
At close: 3:57PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close1.6400
Open1.6500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.6400 - 1.9900
52 Week Range1.0500 - 4.0500
Volume130,325
Avg. Volume81,946
Market Cap75.91M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMar 30, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Business Wire

    Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Participate in Two Upcoming Virtual Investor Conferences

    Schwazze, formerly operating as Medicine Man Technologies, Inc. (OTCQX:SHWZ) ("Schwazze" or "the Company"), announced today that it will be participating in two upcoming virtual investor conferences.

  • Business Wire

    Schwazze, Formerly Operating as Medicine Man Technologies, Inc., Provides Company Update and Announces First Quarter 2020 Financial Results

    Schwazze, formerly operating as Medicine Man Technologies Inc. (OTCQX: SHWZ) ("Schwazze " or "the Company"), today provided a company update and announced financial results for its first quarter ended March 31, 2020.

  • Business Wire

    Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Host First Quarter 2020 Conference Call and Webcast on May 11, 2020

    Schwazze (OTCQX: SHWZ) ("Schwazze " or "the Company"), formerly operating as Medicine Man Technologies Inc. today announced that it will host its first quarter 2020 conference call and webcast on Monday, May 11, 2020 at 4:30 p.m. ET.

  • High Times Selects Retail Veteran Peter Horvath as CEO Ahead of New Stock Listing
    IPO-Edge.com

    High Times Selects Retail Veteran Peter Horvath as CEO Ahead of New Stock Listing

    High Times Set to Expand Quickly with Cannabis Dispensaries and E-Commerce Horvath Brings Decades of Retail, Digital Sales Experience including Aerie, Victoria’s Secret Horvath Also Led IPO Process, Public Investor Comms at DSW, Green Growth Brands By John Jannarone, IPO Edge Hightimes Holding Corp., owner of the eponymous magazine, has hired Peter Horvath as its new CEO, […]

  • High Times Buys 13 Dispensaries from Harvest, Gains Instant Cannabis Retail Foothold Before Listing
    IPO-Edge.com

    High Times Buys 13 Dispensaries from Harvest, Gains Instant Cannabis Retail Foothold Before Listing

    Rendering of a High Times Dispensary By John Jannarone, IPO Edge Hightimes Holding Corp., owner of the eponymous magazine, entered a purchase agreement to buy 13 active and planned retail dispensaries from Harvest Health and Recreation, Inc. for $80 million in cash and stock, giving the company an almost instant foothold in California’s cannabis market. […]

  • Business Wire

    Medicine Man Technologies, Inc. Announces Corporate Brand Change to Schwazze

    Medicine Man Technologies Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "the Company") today announced that the Company will now be doing business as Schwazze (pronounced SHHwahZZ). The new branding reflects the Company’s goal to create a dynamic, innovative culture and brand identity while supporting the current and future house of brands as Schwazze continues to grow.

  • Business Wire

    Schwazze, Formerly Known as Medicine Man Technologies, Inc., Announces the Closing of the Mesa Organics Acquisition

    Schwazze, formerly known as Medicine Man Technologies Inc. (OTCQX:MDCL) ("Schwazze " or "the Company") today announced that it has completed its acquisition of Mesa Organics and its Purplebee’s business.

  • Business Wire

    Medicine Man Technologies Provides Company Update and Announces Fourth Quarter and Full Year 2019 Financial Results

    Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "the Company") today provided a company update and announced financial results for its fourth quarter and full year 2019.

  • Business Wire

    Medicine Man Technologies Launches Online Marketplace for Strategic Partners’ Dispensary Operations

    Medicine Man Technologies, Inc. (OTCQX:MDCL) ("Medicine Man Technologies" or "the Company") today launched a collective platform to support strategic partners through COVID-19.

  • High Times Achieves Vertical Integration with Cannabis Production Ahead of Stock Listing
    IPO-Edge.com

    High Times Achieves Vertical Integration with Cannabis Production Ahead of Stock Listing

    By John Jannarone, IPO Edge High Times is now vertically integrated. Formally known as Hightimes Holding Corp., the owner of the eponymous magazine and operator of Cannabis Cup events, announced it has a signed letter of intent to acquire California-based cannabis holding company Humboldt Heritage Inc. along with its subsidiaries Humboldt Sun Growers Guild and […]

  • Business Wire

    Medicine Man Technologies to Host Fourth Quarter 2019 Conference Call and Webcast on March 30, 2020

    Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "the Company") today announced that it will host its fourth quarter 2019 conference call and webcast on Monday, March 30, 2020 at 4:30 p.m. ET.

  • Business Wire

    Medicine Man Technologies Names Nirup Krishnamurthy as Chief Integration and Information Officer

    Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "the Company") today announced Nirup Krishnamurthy has joined the Company as Chief Integration and Information Officer, reporting directly to Justin Dye, Chief Executive Officer.

  • Business Wire

    Medicine Man Technologies Names Shane Sampson as Chief Marketing and Merchandising Officer

    Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "the Company") today announced Shane Sampson has been named Chief Marketing and Merchandising Officer, reporting directly to Justin Dye, Chief Executive Officer. In this newly created role, Sampson will provide strategic direction and manage tactical execution of the Company’s marketing, merchandising, brand management, IP licensing programs, digital strategy including e-commerce, and retail operations.

  • Business Wire

    Medicine Man Technologies Becomes the First Publicly Traded Company Approved for Suitability by Colorado’s Marijuana Enforcement Division

    Medicine Man Technologies Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "the Company") announced that the Marijuana Enforcement Division (MED), a division of Colorado Department of Revenue, has approved the Company’s application for suitability.

  • Business Wire

    Medicine Man Technologies’ New Leadership Team Participates in Benzinga Cannabis Capital Conference

    Medicine Man Technologies Inc. (OTCQX: MDCL) recently attended and presented at the Benzinga Cannabis Capital Conference in Miami Beach, Florida.

  • CNW Group

    Growth Company Investor Presentations Now Available for On-Demand Viewing

    Growth Company Investor Presentations Now Available for On-Demand Viewing

  • 3 Promising Cannabis Stocks Set to Expand Into the Colorado Market
    TipRanks

    3 Promising Cannabis Stocks Set to Expand Into the Colorado Market

    One of the more interesting stories in the U.S. cannabis market is the opening up of the developed cannabis market in Colorado. Prior to the passing of Colorado’s House Bill 19-1090, publicly traded companies weren’t allowed to own or invest in Colorado cannabis businesses.The bill went into effect on November 1, 2019 opening up the $1.6 billion market opportunity to public companies previously focused on new states opening up recreational use such as Illinois. The state has long been used as an example for the regulatory environment such as the high level of dispensaries compared to the relatively low levels in Canada. The main drawback has been the lack of public investments.According to estimates, Colorado has one retail store per every 10,000 residents. The state first legalized cannabis back in 2014 and has over 560 outlets serving a population of 5.7 million residents.The state serves as an example of the ramp up period needed to reach normalized cannabis sales. Back in 2014, Colorado started with slightly above $40 million in monthly sales and recently topped $160 million to reach $1.6 billion in annual sales. Sales growth has nearly plateaued since the fourth year of legalization with sales topping $1.5 billion in 2017. Also worth noting, medical marijuana sales have only declined since the original sales levels of $30 million monthly.With this in mind, we’ve delved into three U.S. companies set to expand into the well-established Colorado cannabis market in an attempt to consolidate the market. Using TipRanks’ Stock Comparison tool, we lined up the trio alongside each other to get the lowdown on what the near-term holds for these cannabis players.Columbia Care (CCHWF)Columbia Care made the most direct move into the Colorado cannabis market with the purchase of The Green Solution (TGS) for $140 million. TGS is listed as the largest vertically integrated cannabis operation in the state with trailing proforma revenues of $73 million.TGS operates 23 dispensaries in Colorado now with 48,000 pounds of cultivation capacity with combined indoor greenhouse and outdoor flower. The company has plans to expand cultivation to 150,000 pounds by 2023 providing for over 200% growth in the next few years.Columbia Care suggests the deal priced at 1.6x 2020E sales or the equivalent of $87.5 million in revenue from TGS. The deal price is relatively low due to the limited growth expected from Colorado in general and the acquisition target specifically.In total, Columbia Care forecasts a total US footprint of 93 facilities covering 15 jurisdictions in the U.S. with an addressable market of 155 million people. The deal nearly doubles the size of the MSO making Columbia care a suddenly large player in the cannabis business while increasing the path to profits when the deal closes in the 1H of the year.Columbia Care only has a market value of $740 million with quarterly revenues of $22 million. The company is definitely a less risky way to participate in the consolidation of the Colorado cannabis market.Wall Street analysts are on the same page. 3 Buys compared to no Holds or Sells add up to a Strong Buy consensus rating. Additionally, the $10.82 average price target implies 252% upside potential. (See Columbia Care's price targets and analyst ratings on TipRanks)Medicine Man Technologies (MDCL)The one stock now most tied to the new rules in Colorado is Medicine Man Technologies. The company has announced 12 deals to consolidate a whole list of cannabis operators when the deals are finalized in the next few months.Once closing all of the deals, the company predicts having 12 cultivation operations, seven product manufacturing operations, 34 dispensaries along with research, development and innovation assets. Medicine Man forecasts the combined*- businesses generating 20% EBITDA margins with a goal of reaching 30% margins via collaborative growth and economies of scale in the future.Prior to the deals closing, Medicine Man generated Q3 revenues of only $5.3 million with a net loss of $1.8 million. The company had a cash balance of $15.2 million. Most of these numbers are irrelevant due to the pending acquisitions.Medicine Man will need a strong management team to carry off the integration of a dozen separate business units working on a range of products from dispensaries to edibles to cultivation and production facilities. The stock is the best way to obtain a pure play in the Colorado market, but the financials of the company are still largely unknown. Due to the potential here, the stock trades above the levels from last year.Curaleaf (CURLF)The last stock set to benefit from the new laws allowing public companies to invest in Colorado is more of a speculation. Curaleaf is in the process of becoming the largest cannabis company in the world and the company recently obtained one of the 14 medical marijuana licenses in Utah.The logical conclusion to the large ambitions of Curaleaf is that the Utah business provides for the easy step across the state line to Colorado. The company recently closed the Select deal and has another major pending deal with Grassroots to enter the Illinois market. Once these deals are done, the company will likely return back to looking for more deals.While these other states offer growth opportunities, Curaleaf has national ambitions and the establishment of operations in Colorado is only logical. With over 500 dispensaries in a competitive market, one can easily foresee the company making a similar deal as Columbia Care to acquire an established chain in need of capital or better management to grow operations and consolidate market share.Curaleaf is forecasted to top $1 billion in annual sales this year so a similar move to Columbia Care won’t move the needle drastically, but rather Colorado provides a more certain growth opportunity and likely positive EBITDA to help build the business. The stock is trading close to the lows below $7 despite the substantial opportunities still ahead in the U.S. cannabis sector due to opportunities in Colorado.What does the rest of the Street think? As it turns out, 7 out of 8 analysts that have published a recent review see the stock as a Buy, making the consensus rating a Strong Buy. Adding to the good news, the $9.13 average price target indicates 44% upside potential. (See Curaleaf's stock-price forecast and analyst ratings on TipRanks)

  • Live Investor Conference & Webinar: Growth Company CEOs Present February 20th
    PR Newswire

    Live Investor Conference & Webinar: Growth Company CEOs Present February 20th

    Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, February 20th with the first live webcast at 9:30 AM ET

  • OTC Markets Group Announces the 2020 OTCQX Best 50
    CNW Group

    OTC Markets Group Announces the 2020 OTCQX Best 50

    OTC Markets Group Announces the 2020 OTCQX Best 50

  • High Times Plans Flagship Retail Stores, Clearing Way to Sell Cannabis through Dispensaries
    IPO-Edge.com

    High Times Plans Flagship Retail Stores, Clearing Way to Sell Cannabis through Dispensaries

    Deals Signed with Holders of Dispensary Licenses in Los Angeles and Las Vegas By John Jannarone High Times announced it will open two flagship retail stores offering cannabis under dispensary licenses, giving the strongest brand in the marijuana industry a new engine of growth as it prepares for a public listing. Formally known as Hightimes […]

  • Benzinga

    Starbuds CEO Brian Ruden Joins Medicine Man Board

    Vertically integrated seed-to-sale cannabis company Medicine Man (OTCQX: MDCL) announced Monday that Brian Ruden is the newest addition to the company's board. Ruden is the co-founder and CEO of Starbuds, a chain of dispensaries with operations in Colorado, Hawaii, Louisiana, Maryland, Massachusetts, Oklahoma and Washington, D.C. "Brian joins our board at the forefront of the company's next stage of growth," Medicine Man CEO Justin Dye said in a statement, adding that Starbuds is on Medicine Man’s list of announced pending acquisitions.

  • Medicine Man Technologies Announces Appointment of Brian Ruden, Co-Founder and CEO of the Starbuds Chain of Dispensaries, to its Board of Directors
    PR Newswire

    Medicine Man Technologies Announces Appointment of Brian Ruden, Co-Founder and CEO of the Starbuds Chain of Dispensaries, to its Board of Directors

    Medicine Man Technologies Inc. (OTCQX: MDCL) (the "Company") announced the election of Brian Ruden to its Board of Directors. Ruden is the co-founder and CEO of the Starbuds chain of dispensaries and a recognized business leader in the cannabis community with extensive regulated cannabis knowledge and expertise.

  • Medicine Man Technologies Strengthens Leadership Team
    PR Newswire

    Medicine Man Technologies Strengthens Leadership Team

    Medicine Man Technologies Inc. (OTCQX: MDCL) announced today several changes to its executive leadership team. The changes reflect a thoughtful and strategic approach to long-term growth for the organization.

  • Medicine Man Technologies, a Key Proponent of Colorado's HB19-1090, Slated for Record Growth with Passing of Historic "PubCo" Bill
    PR Newswire

    Medicine Man Technologies, a Key Proponent of Colorado's HB19-1090, Slated for Record Growth with Passing of Historic "PubCo" Bill

    Medicine Man Technologies (OTCQX: MDCL), one of the state's pioneers in the cannabis industry, entered into term sheets with 12 of Colorado's cannabis businesses since the recent passing of Colorado's House Bill 19-1090. HB19-1090 or the "PubCo" bill allows publicly traded companies to own and invest in Colorado cannabis businesses. The Company was one of the first publicly traded companies to submit suitability and change of ownership applications to the Marijuana Enforcement Division to apply for approval to acquire Mesa Organics, one of the announced pending acquisitions, as part of the new legislation.